Terfluranol
Synthetic estrogen
From Wikipedia, the free encyclopedia
Terfluranol (INN, BAN; development code BX-428) is a synthetic, nonsteroidal estrogen of the stilbestrol group related to diethylstilbestrol that was developed for the treatment of breast cancer but was never marketed.[1][2] It was described in the medical literature in 1974.[1]
| Clinical data | |
|---|---|
| ATC code |
|
| Identifiers | |
| |
| CAS Number | |
| PubChem CID | |
| ChemSpider | |
| UNII | |
| ChEMBL | |
| CompTox Dashboard (EPA) | |
| Chemical and physical data | |
| Formula | C17H17F3O2 |
| Molar mass | 310.316 g·mol−1 |
| 3D model (JSmol) | |
| |
| |